PDSB icon

PDS Biotechnology
PDSB

Overview Fund Activity

60 hedge funds and large institutions have $12.2M invested in PDS Biotechnology in 2018 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 17 increasing their positions, 13 reducing their positions, and 18 closing their positions.

Holders
60
Holders Change
+3
Holders Change %
+5.26%
% of All Funds
1.38%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
21
Increased
17
Reduced
13
Closed
18
Calls
–
Puts
$9K
Net Calls
-$9K
Net Calls Change
-$9K

Top Buyers

1
PAMU
1
Pictet Asset Management (UK)
United Kingdom
$420K
2
RCM
2
RA Capital Management
Massachusetts
$337K
3
BlackRock
3
BlackRock
New York
$1.39M
4
AG
4
Algert Global
California
$132K
5
ECM
5
Element Capital Management
New York
$130K

Top Sellers

1
Franklin Resources
1
Franklin Resources
California
$0
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$0
3
VMI
3
VHCP Management II
New York
$0
4
ACP
4
Acuta Capital Partners
California
$0
5
EAM
5
Eagle Asset Management
Florida
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Parallax Volatility Advisers
76
Parallax Volatility Advisers
California
– -$28K -151 Closed
Bank of Montreal
77
Bank of Montreal
Ontario, Canada
– -$9K -50 Closed
LTFS
78
Ladenburg Thalmann Financial Services
Florida
– -$2K -13 Closed
1 2 3
4